Top

European Journal of Nuclear Medicine and Molecular Imaging

Published in:

13-08-2022 | Prostate Cancer | Letter to the Editor

Lymph node classification in E-PSMA reporting guidelines for PSMA-PET

Authors: Evyn G. Arnfield, Matthew J. Roberts, David A. Pattison

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 1/2022

Excerpt

Dear Sir, …

Ceci F, Oprea-Lager DE, Emmett L, Adam JA, Bomanji J, Czernin J, et al. E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET. Eur J Nucl Med Mol Imaging. 2021;48:1626–38. https://doi.org/10.1007/s00259-021-05245-y.CrossRefPubMedPubMedCentral

Eiber M, Herrmann K, Calais J, Hadaschik B, Giesel FL, Hartenbach M, et al. Prostate cancer molecular imaging standardized evaluation (PROMISE): proposed miTNM classification for the interpretation of PSMA-ligand PET/CT. J Nucl Med. 2018;59:469–78. https://doi.org/10.2967/jnumed.117.198119.CrossRefPubMed

Buyyounouski MK, Choyke PL, Kattan MW, McKenney JK, Srigley JR, Barocas DA, et al. Prostate. In: Amin MB, Edge SB, Greene FL, Byrd DR, Brookland RK, Washington MK, et al, editors. New York: Springer; 2017. p. 715–726.

Gospodarowicz MK, Mason M. Urological tumours. In: Brierley JD, Gospodarowicz MK, Wittekind C, Union for International Cancer Control, editors. Chichester, Hoboken: John Wiley & Sons, Inc.; 2017. p. 187–210.

Hofman MS, Lawrentschuk N, Francis RJ, Tang C, Vela I, Thomas P, et al. Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study. Lancet. 2020;395:1208–16. https://doi.org/10.1016/s0140-6736(20)30314-7.CrossRefPubMed

Cheng L, Montironi R, Bostwick DG, Lopez-Beltran A, Berney DM. Staging of prostate cancer. Histopathology. 2012;60:87–117. https://doi.org/10.1111/j.1365-2559.2011.04025.x.CrossRefPubMed

Title: Lymph node classification in E-PSMA reporting guidelines for PSMA-PET
Authors: Evyn G. Arnfield
Matthew J. Roberts
David A. Pattison
Publication date: 13-08-2022
Publisher: Springer Berlin Heidelberg
Keywords: Prostate Cancer
Metastasis
Prostate Cancer
Published in: European Journal of Nuclear Medicine and Molecular Imaging / Issue 1/2022
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-022-05943-1

At a glance: The STEP trials

Springer Medicine

Lymph node classification in E-PSMA reporting guidelines for PSMA-PET

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2022

CXCR4-targeted molecular imaging after severe SARS-Cov-2 infection

Reducing instability of inter-subject covariance of FDG uptake networks using structure-weighted sparse estimation approach

Functional biomarkers derived from computed tomography and magnetic resonance imaging differentiate PDAC subgroups and reveal gemcitabine-induced hypo-vascularization

Interplay of tau and functional network connectivity in progressive supranuclear palsy: a [18F]PI-2620 PET/MRI study

Pilot-phase PET/CT study targeting integrin αvβ6 in pancreatic cancer patients using the cystine-knot peptide–based 18F-FP-R01-MG-F2

Correction to: Coronavirus (COVID-19) pandemic mediated changing trends in nuclear medicine education and training: time to change and scintillate